Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pollak

Showing results (191-200 of 326) with videos related to

Pageof 33
Sort By:
Cell Transplantation|March 1, 1994
Transplantation of hepatocytes: an in-vitro and in-vivo study in caninesP A Rivas, A J Fabrega, D Schwartz, et al.
Heart (British Cardiac Society)|November 18, 2004
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillationP T Ellinor, R K Moore, K K Patton, et al.
Digestive Diseases and Sciences|May 1, 1994
Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantationS Kazi, S Prasad, R Pollak, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factorsJohn P Forman, Naomi D L Fisher, Martin R Pollak, et al.
Glomerular Diseases|March 18, 2024
<i>APOL1</i> Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K VariantRasheed Gbadegesin, Elena Martinelli, Yask Gupta, et al.
Surgery|October 1, 1984
Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized studyM F Mozes, D G Spigos, R Pollak, et al.
Transplantation Proceedings|August 1, 1993
In vitro response to immunosuppressive agents in blacksM Ward, V A Lazda, P J Gaddis, et al.
Kidney International|October 16, 2019
Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype backgroundHerbert Lannon, Shrijal S Shah, Leny Dias, et al.
Transplantation Proceedings|February 1, 1989
Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejectionS A Veremis, M S Maddux, I Y Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2007
Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinityAstrid Weins, Johannes S Schlondorff, Fumihiko Nakamura, et al.
Pageof 33

Showing results (191-200 of 326) with videos related to

Sort By:
Pageof 33
Cell Transplantation|March 1, 1994
Transplantation of hepatocytes: an in-vitro and in-vivo study in caninesP A Rivas, A J Fabrega, D Schwartz, et al.
Heart (British Cardiac Society)|November 18, 2004
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillationP T Ellinor, R K Moore, K K Patton, et al.
Digestive Diseases and Sciences|May 1, 1994
Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantationS Kazi, S Prasad, R Pollak, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factorsJohn P Forman, Naomi D L Fisher, Martin R Pollak, et al.
Glomerular Diseases|March 18, 2024
<i>APOL1</i> Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K VariantRasheed Gbadegesin, Elena Martinelli, Yask Gupta, et al.
Surgery|October 1, 1984
Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized studyM F Mozes, D G Spigos, R Pollak, et al.
Transplantation Proceedings|August 1, 1993
In vitro response to immunosuppressive agents in blacksM Ward, V A Lazda, P J Gaddis, et al.
Kidney International|October 16, 2019
Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype backgroundHerbert Lannon, Shrijal S Shah, Leny Dias, et al.
Transplantation Proceedings|February 1, 1989
Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejectionS A Veremis, M S Maddux, I Y Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2007
Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinityAstrid Weins, Johannes S Schlondorff, Fumihiko Nakamura, et al.
Pageof 33